lncRNA KCNQ1OT1 reverses the effect of sevoflurane on hepatocellular carcinoma progression via regulating the miR-29a-3p/CBX3 axis
Braz. j. med. biol. res; 54 (7), 2021
Sevoflurane (SEVO) is widely applied as an anesthetic, which exerts antitumor capacity in various cancers, including hepatocellular carcinoma (HCC). Previous studies indicated that long non-coding RNA KCNQ1 opposite strand/antisense transcript 1 (KCNQ1OT1) was upregulated, while microRNA-29a-3p (miR-29a-...
Carcinoma Hepatocelular/tratamiento farmacológico, Carcinoma Hepatocelular/genética, Proteínas Cromosómicas no Histona, Neoplasias Hepáticas/tratamiento farmacológico, Neoplasias Hepáticas/genética, MicroARNs/genética, Canales de Potasio con Entrada de Voltaje, ARN Largo no Codificante/genética, Sevoflurano/farmacología